<DOC>
	<DOCNO>NCT01301469</DOCNO>
	<brief_summary>The purpose study evaluate efficacy HES 130/0.42 electrolyte infusion comparison HES 130/0.4 sodium chloride infusion .</brief_summary>
	<brief_title>Comparison HES 130 Balanced Unbalanced Solution</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Inclusion : Male female ( non pregnant ) patient ; 18 70 year Elective noncardiac surgery ( except pancreatic neurological surgery ) estimate operation duration 2 hour longer General anesthesia Voluntary consent Exclusion : Patients ASAclass III IV , Cardiac insufficiency NYHA class III . IV BMI &lt; 18 &gt; 29 Patients daily urine output &lt; 1L Patients hemodialysis Abnormal liver renal function ( i. e. upper limit normal range ) Abnormal coagulation function ( prothrombin time ( PT ) 3 second high normal activate partial thromboplastin time ( APTT ) 10 second high normal ) Hgb &lt; 10g/dl HCT &lt; 30 % Potassium , sodium chloride upper limit normal laboratory History diabetes mellitus Known history mental neurological disorder , epileptic seizure . History hypertension and/or take betareceptor blocker history atrial fibrillation Patients know hypersensitivity contraindication HES excipients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>